TGFB1 and melanoma: Interestingly, we identified a myeloid-derived suppressor cell CD14+PD-L1+FKBP51s+ in peripheral blood of melanoma patients, expressing high TGF-β levels and apparently associated with resistance to ipilimumab [40].